PROVECTUS BIOPHARMACEUTICALS, INC. Common Stock Shares Outstanding

Quick Answer

PROVECTUS BIOPHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 420.28 million shares for the year ending 2025.

  • PROVECTUS BIOPHARMACEUTICALS, INC. showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from PROVECTUS BIOPHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 26, 2026.
  • XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 16 years of available data (2010 to 2025), PROVECTUS BIOPHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 360.3%.
  • Historical annual values: Fiscal year 2025: 420.28 million shares | Fiscal year 2024: 420.28 million shares | Fiscal year 2023: 419.52 million shares | Fiscal year 2022: 419.45 million shares | Fiscal year 2021: 419.45 million shares | Fiscal year 2020: 398.81 million shares | Fiscal year 2019: 389.89 million shares | Fiscal year 2018: 384.61 million shares | Fiscal year 2017: 370.96 million shares | Fiscal year 2016: 364.77 million shares | Fiscal year 2015: 204.98 million shares | Fiscal year 2014: 184.80 million shares | Fiscal year 2013: 159.75 million shares | Fiscal year 2012: 118.43 million shares | Fiscal year 2011: 110.60 million shares | Fiscal year 2010: 91.30 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: